Cystic macroprolactinoma: primary medical treatment?
Delgrange
E
E
Gustin
T
T
D000293:Adolescent; D000077465:Cabergoline; D020863:Central Nervous System Cysts / Q000150:complications* / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006261:Headache / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy* / Q000209:etiology*; D016896:Treatment Outcome
D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline